Second Colombian Symposium on Convalescent Plasma in COVID-19

The PC-COVID-19 Group invites to the 2nd Colombian Symposium on Convalescent Plasma in COVID-19.

This symposium will offer information about the clinical trials carried out during the pandemic and the role of INVIMA in their development. The final results of the "PC-Covid-19 Project" will be presented, which included the clinical trial, immunological evaluation and a meta-analysis.

The PC-COVID-19 Group is made up of researchers from the Center for the Study of Autoimmune Diseases (CREA) of the Universidad del Rosario, in Bogotá; from the CES University of Medellín; of the District Institute of Science, Biotechnology and Innovation in Health (IDCBIS), of Bogotá; of the University Foundation of Health Sciences (FUCS) and of Services and Advice in Infectology (SAI), of Bogotá.

The PC-COVID-19 project was carried out at the Clínica del Occidente and the Mayor Méderi University Hospital, in Bogotá; and at the CES Clinic in Medellín; and it was financed by the Universidad del Rosario, IDCBIS, Grupo ISA and Suramericana.


Date: January 21, 2021

Time: 10:00 a.m. -12: 00m.


10:00 – 10:10 Presentation

Gustavo Quintero Hernández, MD, MSc.

Dean, School of Medicine and Health Sciences,

Rosario University, Bogotá

10:10 – 10:30 Clinical trials during the Pandemic. On the importance of research and the role of INVIMA

Julio C. Aldana, MD.

Director General of the National Institute for Food and Drug Surveillance (INVIMA), Bogotá

10:30 – 10:50 PC-COVID-19 study. Final results.

Rubén Manrique, PhD

CES University, Medellín

Researcher Group PC-COVID-19

10:50 – 11:10 Safety and efficacy of convalescent plasma in COVID-19. What do the meta-analyzes show?

Manuel Rojas, MD, MSc

CREA, University of Rosario

Researcher Group PC-COVID-19

11:10 – 11:30 Mechanisms of action of convalescent plasma

Yenny Acosta, PhD

CREA, Universidad del Rosario, Bogotá

Researcher Group PC-COVID-19

11:30 – 12:00 Discussion.

Moderator: Juan Manuel Anaya, director of the Center for Studies of Autoimmune Diseases ( Create ) of the Universidad del Rosario.

Know all the news